SYNTHESIS OF AN ORALLY-ACTIVE PAF ANTAGONIST OF THE N-[4-(3-PYRIDINYL) BUTYL]PENTADIENAMIDE CLASS

被引:0
|
作者
MANCHAND, PS
SCHWARTZ, A
WOLFF, S
BELICA, PS
MADAN, P
PATEL, P
SAPOSNIK, SJ
机构
关键词
D O I
暂无
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The PAF antagonist [R-(E,E)]-5-(4-methoxyphenyl)-N-[1-methyl-4-(3-pyridinyl)butyl]-2,4-decadienamide (2) was synthesized from (S)-alpha-methyl-3-pyridinebutanol (14), which was obtained either from ethyl lactate or by enantioselective kinetic hydrolysis of its racemate using the lipase derived from Pseudomonas cepacia (syn. P. fluorescens). Mesylation of 14, followed by azide displacement and hydrogenation, produced amine (7), which was coupled with the p-nitrophenol ester (8) to give 2. The direct coupling of (E,E)-5-(4-methoxyphenyl)-2,4-decadienoic acid (27) with azide (24) in the presence of tri-n-butylphosphine also gave 2. Acid (27) was prepared by a vinylogous Reformatsky reaction between ketone (25) and methyl 4-bromocrotonate.
引用
收藏
页码:1351 / 1369
页数:19
相关论文
共 50 条
  • [21] Preparation of carbon-14 labeled N-(2-ethyl-3-chloro-4-pyridinyl)-4-(4-chlorophenoxy)phenylacetamide
    Pearson, NR
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1998, 41 (02): : 151 - 157
  • [22] Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D3 receptor partial agonist in animal models of cocaine abuse
    Gyertyan, Istvan
    Kiss, Bela
    Gal, Krisztina
    Laszlovszky, Istvan
    Horvath, Attila
    Gemesi, Larisza I.
    Saghy, Katalin
    Pasztor, Gabriella
    Zajer, Maria
    Kapas, Margit
    Csongor, Eva Agai
    Domany, Gyorgy
    Tihanyi, Karoly
    Szombathelyi, Zsolt
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (03): : 1268 - 1278
  • [23] Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist
    Ito, Satoru
    Satoh, Atsushi
    Nagatomi, Yasushi
    Hirata, Yukari
    Suzuki, Gentaroh
    Kimura, Toshifumi
    Satow, Akio
    Maehara, Shunsuke
    Hikichi, Hirohiko
    Hata, Mikiko
    Kawamoto, Hiroshi
    Ohta, Hisashi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (22) : 9817 - 9829
  • [24] Formulation and evaluation of Flupirtine N-[2-amino-6-[(4-fluorophenyl) methylamino]-3-pyridinyl]carbamic acid ethyl ester nanosuspension by precipitation method
    Rijivana, S.
    Akashpriyadharashan, S.
    Kumar, K. Praveen
    Saravanan, G.
    Kiruthika, S.
    INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY, 2024, 34 (04) : 561 - 566
  • [25] NOVEL ORALLY ACTIVE INHIBITORS OF PASSIVE CUTANEOUS ANAPHYLAXIS IN RATS - N-[2-(4-PYRIDINYL)-4-PYRIMIDINYL]UREAS AND DIALKYL[[[2-(4-PYRIDINYL)-4-PYRIMIDINYL]AMINO]METHYLENE]MALONATES
    LESHER, GY
    SINGH, B
    MIELENS, ZE
    JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (07) : 837 - 842
  • [26] Synthesis and Antitumor Activity of N-[4-(t-Butyl)-5-benzylthiazol-2-yl] aminoacetamides
    Tang, Yuting
    Ding, Na
    Wu, Zhilin
    Ye, Jiao
    Shen, Kun
    Hu, Aixi
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2017, 37 (03) : 675 - 682
  • [27] ACRYLAMIDE DERIVATIVES AS ANTIALLERGIC AGENTS .2. SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIPS OF N-[4-[4-(DIPHENYLMETHYL)-1-PIPERAZINYL]BUTYL]-3-(3-PYRIDYL)ACRYLAMIDES
    NISHIKAWA, Y
    SHINDO, T
    ISHII, K
    NAKAMURA, H
    KON, T
    UNO, H
    JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) : 583 - 593
  • [28] PHARMACOLOGY OF N-[4-(4-MORPHOLINYLCARBONYL)BENZOYL]-L-VALYL-N-[3,3,4,4,4-PENTAFLUORO-1-(1-METHYLETHYL)-2-OXOBUTYL]-L-PROLINAMIDE (MDL-101,146) - A POTENT ORALLY-ACTIVE INHIBITOR OF HUMAN NEUTROPHIL ELASTASE
    DURHAM, SL
    HARE, CM
    ANGELASTRO, MR
    BURKHART, JP
    KOEHL, JR
    MARQUART, AL
    MEHDI, S
    FEET, NP
    JANUSZ, MJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 270 (01): : 185 - 191
  • [29] Neuropsychopharmacological characterization of a sulfonamide compound [4-(3-cyclopentyl-indole-1-sulfonyl)-N-(tetrahydropyran-4-ylmetryl)-benzamide], as a novel, potent, selective and orally active CB1 cannabinoid receptor antagonist
    Nomikos, G.
    Schaus, J.
    Hitchcock, S.
    Porter, A.
    Allen, J.
    Jones, W.
    Stratford, R.
    Havel, H.
    Chernet, E.
    Phebus, L.
    Hart, J.
    Alexander-Chacko, J.
    Li, X.
    Davis, R.
    McKinzie, D.
    Witkin, J.
    Sindelar, D. K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S208 - S208
  • [30] Design, synthesis, and evaluation of N-(4-(4-phenyl piperazin-1-yl) butyl)-4-(thiophen-3-yl) benzamides as selective dopamine D3 receptor ligands
    Chen, Peng-Jen
    Taylor, Michelle
    Griffin, Suzy A.
    Amani, Armaghan
    Hayatshahi, Hamed
    Korzekwa, Kenneth
    Ye, Min
    Mach, Robert H.
    Liu, Jin
    Luedtke, Robert R.
    Gordon, John C.
    Blass, Benjamin E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (18) : 2690 - 2694